ScholarIQanswers from OpenAlex

Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy

PaperCitations, authors & open-access status

Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy have?

ScholarIQcitation count

Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy has 836 citations in the OpenAlex counts ScholarIQ stores.

When was Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy published?

ScholarIQyear

Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy has 2015 year in the ScholarIQ index.

What is the open-access status of Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy?

ScholarIQoa status

Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy has hybrid oa status in the ScholarIQ index.

What is the DOI of Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy?

ScholarIQdoi

The DOI for Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy is on the source record.

What is the PMID of Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy?

ScholarIQpmid

The PMID for Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy is on the source record.

What is the OpenAlex record for Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy?

ScholarIQopenalex

The OpenAlex for Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial